Company: ZDAN
Filing Date: 2025-01-10
Form Type: DRS/A
Source: 0001683168-25-000168
Chunk: 274

Company: Zerolimit Technology Holding Co. Ltd.
Filing Date: 2025-01-10
Form: DRS/A
Chunk 274
---
 be registered or filed with, or approved by, the Financial Supervisory Commission of Taiwan
pursuant to relevant securities laws and regulations and may not be offered or sold in Taiwan through a public offering or in circumstances
which constitute an offer within the meaning of the Securities and Exchange Act of Taiwan or relevant laws and regulations that require
a registration, filing, or approval of the Financial Supervisory Commission of Taiwan. No person or entity in Taiwan has been authorized
to offer or sell the Ordinary Shares in Taiwan.

United Kingdom. An
offer of the Ordinary Shares may not be made to the public in the United Kingdom within the meaning of Section 102B of the Financial
Services and Markets Act 2000, as amended, or the FSMA, except to legal entities that are authorized or regulated to operate in the financial
markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities or otherwise in circumstances
that do not require the publication by the company of a prospectus pursuant to the Prospectus Rules of the Financial Services Authority,
or the FSA.

An invitation or inducement
to engage in investment activity (within the meaning of Section 21 of FSMA) may only be communicated to persons who have professional
experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 or in circumstances in which Section 21 of FSMA does not apply to the company.

All applicable provisions
of the FSMA with respect to anything done by the Underwriter in relation to the Ordinary Shares must be complied with in, from or otherwise
involving the United Kingdom.

Israel.
This prospectus does not constitute a prospectus under the Israeli Securities Law, 5728-1968, and has not been filed with or
approved by the Israel Securities Authority. In Israel, this prospectus may be distributed only to, and is directed only at,
investors listed in the first addendum, or the Addendum, to the Israeli Securities Law, consisting primarily of joint investment in
trust funds; provident funds; insurance companies; banks; portfolio managers, investment advisors, members of the Tel Aviv Stock
Exchange Ltd., underwriters, each purchasing for their own account; venture capital funds; entities with equity in excess of NIS 50
million and “qualified individuals,” each as defined in the Addendum (as it may be amended from time to time),
collectively referred to